20:56 , Aug 17, 2017 |  BC Innovations  |  Finance

Built to purpose

With almost 40 start-ups engaging in build-to-buy deals since 2013 and an average 2-4 years for up or down decisions, the next year could see a spate of acquisitions -- or options declined -- that...
07:00 , Apr 20, 2015 |  BioCentury  |  Finance

X marks the spot for Atlas

With last week's close of its oversubscribed $280 million tenth fund, Atlas Venture completed its transition into a solely life sciences-focused venture firm looking at early stage investments in therapeutics. Atlas was a hybrid focused...
07:00 , Mar 23, 2015 |  BioCentury  |  Strategy

Show me the value

At a time when industry is struggling mightily with how to demonstrate the value of its products to payers and patients and translate that value into pricing, The Medicines Co. could provide some lessons. The...
02:24 , Feb 5, 2015 |  BC Extra  |  Company News

The Medicines Co. acquires Annovation

The Medicines Co. (NASDAQ:MDCO) exercised its option to acquire Annovation Biopharma Inc. (Cambridge, Mass.) for $28.4 million in cash up front. Annovation shareholders are eligible for up to $26.3 million in clinical and regulatory milestones,...
07:00 , Oct 6, 2014 |  BioCentury  |  Finance

Atlas' next chapter

After separating from the tech group, Atlas Venture 's healthcare team plans to stick to the early stage investing strategy the firm says has provided returns in the top quartile of life science VCs. For...
08:00 , Jan 20, 2014 |  BioCentury  |  Finance

Asset-centric milestone

Atlas Venture and Eli Lilly and Co. both checked first-time milestones when the pharma decided to reacquire its anti- CGRP antibody for migraine prevention from Arteaus Therapeutics LLC . Last week, Lilly exercised its option...
07:00 , Sep 17, 2012 |  BC Week In Review  |  Financial News

Annovation Biopharma completes venture financing

Annovation Biopharma Inc. , Cambridge, Mass.   Business: Neurology   Date completed: 9/10/12   Type: Venture financing   Raised: $8 million   Investors: Atlas Venture; Partners Innovation Fund; The Medicines Co.   Note: Annovation said...
07:00 , Sep 17, 2012 |  BC Week In Review  |  Company News

Annovation Biopharma board of directors update

Annovation Biopharma Inc. , Cambridge, Mass.   Business: Neurology   Appointed: Carl Berke, partner at Partners Innovation Fund; Jason Campagna, VP of global health and medical outcomes at The Medicines Co. ; and Jean Francois...
07:00 , Sep 17, 2012 |  BioCentury  |  Finance

Hitting the books

Hitting the books Anesthesia play Annovation Biopharma Inc. is the second company to emerge from Atlas Venture 's Atlas Venture Development Corp. asset-centric initiative and is the first that is working with assets from academia....
01:13 , Sep 11, 2012 |  BC Extra  |  Company News

Annovation debuts to develop anesthetics

Annovation Biopharma Inc. debuted to develop anesthetics with $8 million in a series A round from Atlas Venture; Partners Innovation Fund; and The Medicines Co. (NASDAQ:MDCO). Annovation is working on small molecule GABA-A receptor agonists...